• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COLLAGEN MATRIX, INC. DURAMATRIX ONLAY; DURAMATRIX COLLAGEN DURA SUBSTITUTE MEMBRANE - ONLAY AND SUTURABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COLLAGEN MATRIX, INC. DURAMATRIX ONLAY; DURAMATRIX COLLAGEN DURA SUBSTITUTE MEMBRANE - ONLAY AND SUTURABLE Back to Search Results
Model Number CDSLM45
Health Effect - Clinical Code Cerebrospinal Fluid Leakage (1772)
Date of Event 09/12/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device history record review and additional qc reserve sample testing confirms that the product met release criteria.There are no indications that the product would not perform as designed.
 
Event or Problem Description
The clinician reported that a revision surgery was performed as a result of csf leak 11 days following the initial post area fossa craniotomy.The initial procedure was completed using a combination of duramatrix suturable and duramatrix onlay products.Based on additional feedback provided, the suturing technique during the initial procedure may have been a contributing factor in the event.
 
Event or Problem Description
It was initially reported that the duramatrix onlay (cdslm45) product in combination with duramatrix suturable (dms45; emdr report 2249852-2017-00017) was used as part of a post area fossa craniotomy procedure which resulted in follow-up surgery to fix a cerebrospinal fluid leak.Based on additional information received on 10/11/2018, it has been determined that the duramatrix onlay (cdsml45) product was not used or associated with the initially reported incident.
 
Additional Manufacturer Narrative
Contrary to the initial report, it has been determined that the subject device of this report (duramatrix onlay cdslm45) was not involved in the reported incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURAMATRIX ONLAY
Common Device Name
DURAMATRIX COLLAGEN DURA SUBSTITUTE MEMBRANE - ONLAY AND SUTURABLE
Manufacturer (Section D)
COLLAGEN MATRIX, INC.
15 thornton road
oakland NJ 07436
MDR Report Key6915042
Report Number2249852-2017-00018
Device Sequence Number16264098
Product Code GXQ
UDI-Device Identifier00813954020273
UDI-Public00813954020273
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K061487
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date03/31/2019
Device Model NumberCDSLM45
Device Lot Number1703033023
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 09/13/2017
Supplement Date Received by Manufacturer09/13/2017
Initial Report FDA Received Date10/05/2017
Supplement Report FDA Received Date10/12/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DURAMATRIX SUTURABLE.; DURAMATRIX SUTURABLE
Outcome Attributed to Adverse Event Required Intervention;
-
-